decabromobiphenyl ether has been researched along with Insulin Sensitivity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Dong, F; Feng, W; Liao, T; Mao, G; Shi, X; Tang, J; Wu, X; Yang, L; Zhao, T | 1 |
Abudureman, H; Alimu, A; Jiang, S; Li, M; Liu, Z; Wang, J; Wang, M; Wang, Y | 1 |
2 other study(ies) available for decabromobiphenyl ether and Insulin Sensitivity
Article | Year |
---|---|
Metabolism toxicity and susceptibility of decabromodiphenyl ether (BDE-209) exposure on BRL cells with insulin resistance.
Topics: Animals; Cell Line; Diabetes Mellitus, Type 2; Glucose; Glycogen Synthase Kinase 3 beta; Halogenated Diphenyl Ethers; Insulin Resistance; Phosphatidylinositol 3-Kinases | 2022 |
[Effects of decabromodiphenyl ether on glucose and lipid metabolism and adipocyte factors in C57BL/6 mice].
Topics: Adipocytes; Animals; Blood Glucose; Glucose; Halogenated Diphenyl Ethers; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Rats | 2021 |